Effectiveness of sacubitril–valsartan in cancer patients with heart failure

AIMS: Current guidelines recommend sacubitril/valsartan for patients with heart failure and reduced left ventricular ejection fraction (LVEF), but there is lack of evidence of its efficacy and safety in cancer therapy‐related cardiac dysfunction (CTRCD). Our aim was to analyse the potential benefit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Martín‐Garcia, Ana, López‐Fernández, Teresa, Mitroi, Cristina, Chaparro‐Muñoz, Marinela, Moliner, Pedro, Martin‐Garcia, Agustin C., Martinez‐Monzonis, Amparo, Castro, Antonio, Lopez‐Sendon, Jose L., Sanchez, Pedro L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Short Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160493/
https://ncbi.nlm.nih.gov/pubmed/32022485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12627
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados